Assignee
CLEVELAND BIOLABS INC
US·8 granted patents·8 pending applications·43 citations·filing 2006–2020
Top patents by PatentIndex Score
16 records- 0196US7638485B2Modulating apoptosisCLEVELAND BIOLABS INC·Filed 2006·Granted Dec 29, 2009·29 cites·13 claims
- 0292US10034926B2Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2017·Granted Jul 31, 2018·5 cites·19 claims
- 0390US9006180B2Methods for treating tourniquet-induced injuriesCLEVELAND BIOLABS INC·Filed 2013·Granted Apr 14, 2015·5 cites·13 claims
- 0483US10183056B2Methods and compositions for the treatment of radiation-related disordersCLEVELAND BIOLABS INC·Filed 2015·Granted Jan 22, 2019·3 cites·13 claims
- 0582US10857200B2Methods and compositions for the treatment of radiation-related disordersCLEVELAND BIOLABS INC·Filed 2018·Granted Dec 8, 2020·1 cites·13 claims
- 0675US10780152B2Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2019·Granted Sep 22, 2020·0 cites·19 claims
- 0773US11628201B2Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2020·Granted Apr 18, 2023·0 cites·19 claims
- 0872US10265390B2Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2018·Granted Apr 23, 2019·0 cites·19 claims
- 0968US2018354995A1Flagellin-based agents and uses including effective vaccinationCLEVELAND BIOLABS INC·Filed 2018·Application pending·0 cites
- 1066US2021275627A1Methods and compositions for the treatment of radiation-related disordersCLEVELAND BIOLABS INC·Filed 2020·Application pending·0 cites
- 1165US2017065692A1Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2016·Application pending·0 cites
- 1263US2016206690A1Use of toll-like receptor agonist for treating cancerCLEVELAND BIOLABS INC·Filed 2015·Application pending·0 cites
- 1360US2015182587A1Methods for treating reperfusion injuriesCLEVELAND BIOLABS INC·Filed 2015·Application pending·0 cites
- 1459US2014045747A1Methods for increasing and mobilizing hematopoietic stem cellsCLEVELAND BIOLABS INC·Filed 2013·Application pending·0 cites
- 1551US2015174195A1Methods for increasing and mobilizing hematopoietic stem cellsCLEVELAND BIOLABS INC·Filed 2015·Application pending·0 cites
- 1649US2015328284A1Compositions and methods comprising toll like receptor (tlr) stimulating agents for prophylaxis and therapy for damage to dermal epitheliumCLEVELAND BIOLABS INC·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →